ArticleCancers2021

Site-Specific Dual-Labeling of a VHH with a Chelator and a Photosensitizer for Nuclear Imaging and Targeted Photodynamic Therapy of EGFR-Positive Tumors.

Emma Renard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.